Sigyn Therapeutics Inc
@Sigyn_inc
Followers
93
Following
28
Media
50
Statuses
92
Addressing Life-Threatening Inflammatory Conditions Precipitated by Cytokine Storm Syndrome
San Diego, CA
Joined April 2016
In case you missed it! Jeremy Ferrell, CPA, MBA was recently appointed as Chief Financial Officer of #Sigyn Therapeutics. He brings over 25 years of finance and operations leadership experience to our company. Learn more:
0
0
0
Did you know that regional disparities in sepsis incidence and mortality exist? 85% of sepsis cases and deaths worldwide occur in low- and middle-income countries. We believe that #sigyn extracorporeal system will increase access to innovative therapies around the world.
0
0
0
We're thrilled to announce Alexander S. Yevzlin, M.D., FASN has joined our Scientific Advisory Board. He's a recognized leader in the field of Interventional Nephrology & has been involved in the development of multiple medical devices. $SIGY Learn more: .
0
0
0
Please join us in welcoming H. David Humes, M.D., to our Scientific Advisory Board. Dr. Humes is a world-renowned scholar in the areas of nephrology, acute renal failure, biomaterials, medical devices, and extracorporeal therapy. $SIGY.
0
0
1
Did you know that #cytokinestorm is a life-threatening condition involving elevated levels of circulating cytokines that can be triggered by various therapies, infections, cancers and autoimmune conditions? At #Sigyn we are creating novel therapeutic modalities for this condition
0
0
1
We welcome Ajay Verma, M.D., Ph.D. to our Scientific Advisory Board. He's a recognized thought leader in the field of neurology and drug development, and brings decades of pharmaceutical industry experience to our team. $SIGY .Learn more:
0
0
0
In his CEO Notes, our CEO Jim Joyce provides comprehensive information regarding the development of our lead asset, Sigyn Therapy, which has broad-spectrum potential to help treat inflammatory conditions. $SIGY. Learn more from our suite of #CEONotes:.
sigyntherapeutics.com
0
0
0
What is #SigynTherapy?. We are developing Sigyn Therapy as a broad-spectrum solution to life-threatening inflammatory conditions with limited treatment options. $SIGY. Learn more:.
sigyntherapeutics.com
Sigyn Therapeutics’ novel blood purification therapy (Sigyn Therapy) is designed to mitigate Cytokine Storm Syndrome.
0
0
0
Our mission is to develop novel technologies that use blood purification to save patients’ lives. We're working to the bridge the gap of current therapeutic options through our broad-spectrum technology, #Sigyn Therapy. Learn more:.
sigyntherapeutics.com
Sigyn Therapeutics’ focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions.
0
0
0
Interested in learning more about our work and upcoming presentations and events? Check out the #NewsAndEvents section of our website for the latest and greatest! .
sigyntherapeutics.com
0
0
0
In a recent ep. of @Finding_genius, our CEO Jim Joyce explains the potential benefits of a broad-spectrum blood purification device to treat life-threatening conditions. $SIGY. #TuneIn here:.
findinggeniuspodcast.com
Is purifying blood the future of treating sepsis and many other conditions? While still under development, a new device may revolutionize the field. Press play to learn: Why the definition of...
0
1
1
Improving #patientsafety starts with pursuing better patient outcomes. Learn more about #PatientSafetyAwarenessWeek from @ASHRM:.
ashrm.org
Celebrate National Patient Safety Awareness Week with ASHRM! Join us in advancing patient safety and reducing uncertainty in health care.
0
0
0
#ICYMI: In a recent article from @Biospace, our CEO Jim Joyce covered how #blood detoxification technology like #SigynTherapy can fight antibiotic-resistant microorganisms known as #superbugs. $SIGY. Read more:.
biospace.com
To alleviate the problem of antibiotic-resistant bacteria, or superbugs, several biotechnology companies are developing different strategies to target and kill these microorganisms.
0
0
0
As we progress further into 2022, we are excited to continue sharing updates on #SigynTherapy as it progresses through clinical development. #StayTuned! $SIGY. In the meantime, read more about our work:.
sigyntherapeutics.com
Sigyn Therapeutics’ focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions.
0
0
0
It’s #RareDiseaseDay!. Through our ongoing clinical development, we hope to address a broad-spectrum of issues, including rare conditions like #Hepatic Encephalopathy (#HE). Learn more about supporting patients with rare conditions:.
0
0
1
Cytokine Storm Syndrome underlies many deadly diseases that currently do not have significant therapeutic options. Through our work with #SigynTherapy and #bloodpurification tech, we hope to bring a new lifesaving option to patients. $SIGY . Learn more: .
0
0
0
Sepsis continues to be a severe issue for ill patients; our goal is to address this condition and increase positive outcomes for those affected by #sepsis. #SIGY . Learn more about #SigynTherapy: .
0
2
1
The outbreak of #COVID19 has shifted perspectives regarding therapeutic developments; it is time to consider whether broad-spectrum responses are timelier than overly complicated targeted therapies. Read more from $SIGY CEO Jim Joyce in @MedDeviceNews1:.
0
0
1
Sigyn Therapy is designed to address a broad spectrum of inflammatory targets, including #sepsis, by removing #cytokines and pathogenic markers from the bloodstream. $SIGY. Learn more about #SigynTherapy’s potential range:.
0
0
2